Publicaciones (21) Publicaciones de BEGOÑA ELORZA BARROETA

2020

  1. Solvatochromism in urea/water and urea-derivative/water solutions

    Physical Chemistry Chemical Physics, Vol. 22, Núm. 43, pp. 25165-25176

2013

  1. Nano and microparticulate chitosan-based systems for antiviral topical delivery

    European Journal of Pharmaceutical Sciences, Vol. 48, Núm. 1-2, pp. 216-222

2009

  1. Interactions of 2,2,2-trifluoroethanol with aqueous micelles of Triton X-100

    Journal of Colloid and Interface Science, Vol. 330, Núm. 1, pp. 163-169

  2. Quantification of isonicotinoyl lactosyl hydrazone in oral pharmaceutical dosage forms

    Spectroscopy, Vol. 23, Núm. 3-4, pp. 201-208

1999

  1. Improved RPLC determination of acyclovir using hexylamine as silanol masking agent

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 21, Núm. 3, pp. 619-624

1998

  1. RPLC determination of acyclovir using hexylamine as silanol masking agent

    Journal de Pharmacie de Belgique, Vol. 53, Núm. 3, pp. 164

1997

  1. Stability of liposomal formulations: Action of amphiphilic molecules

    International Journal of Pharmaceutics, Vol. 158, Núm. 2, pp. 173-183

1993

  1. Analysis of the particle size distribution and internal volume of liposomal preparations

    Journal of Pharmaceutical Sciences, Vol. 82, Núm. 11, pp. 1160-1163

  2. Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release

    BBA - Biomembranes, Vol. 1153, Núm. 2, pp. 135-142

  3. Comparison of particle size and encapsulation parameters of three liposomal preparations

    Journal of Microencapsulation, Vol. 10, Núm. 2, pp. 237-248

  4. DSC study of the action of phenylbutazone on DMPC and DPPC bilayers

    International Journal of Pharmaceutics, Vol. 89, Núm. 3, pp. 183-190

  5. DSC study of the action of phenylbutazone on phospholipid phase transitions

    International Journal of Pharmaceutics, Vol. 91, Núm. 1, pp. 1-8

1989

  1. Liposomas: estado de la cuestión. III, aplicaciones terapéuticas y diagnóstico

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 1, pp. 107-112